2015-2027 Global Adalimumab Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 125 pages | ID: 291C40603503EN
Maia Research

Abstracts

The worldwide market for Adalimumab is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
AbbVie
Novartis AG
Mylan
Boehringer Ingelheim
Sandoz
Biogen
Amgen
Pfizer

Major Types Covered
Rheumatoid Arthritis
Psoriatic Arthritis
Psoriasis
Crohn’s disease
Ulcerative colitis

Major Applications Covered
Adults
Children

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Adalimumab Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Adalimumab Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ADALIMUMAB MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ADALIMUMAB MARKET-SEGMENTATION BY TYPE

5.1 Rheumatoid Arthritis
5.2 Psoriatic Arthritis
5.3 Psoriasis
5.4 Crohn’s disease
5.5 Ulcerative colitis

6 GLOBAL ADALIMUMAB MARKET-SEGMENTATION BY APPLICATION

6.1 Adults
6.2 Children

7 GLOBAL ADALIMUMAB MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 AbbVie
  8.1.1 AbbVie Profile
  8.1.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 AbbVie Product/Solution Launches and Enhancements Analysis
  8.1.4 AbbVie Business Overview/Recent Development/Acquisitions
8.2 Novartis AG
  8.2.1 Novartis AG Profile
  8.2.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.2.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.3 Mylan
  8.3.1 Mylan Profile
  8.3.2 Mylan Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Mylan Product/Solution Launches and Enhancements Analysis
  8.3.4 Mylan Business Overview/Recent Development/Acquisitions
8.4 Boehringer Ingelheim
  8.4.1 Boehringer Ingelheim Profile
  8.4.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
  8.4.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.5 Sandoz
  8.5.1 Sandoz Profile
  8.5.2 Sandoz Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Sandoz Product/Solution Launches and Enhancements Analysis
  8.5.4 Sandoz Business Overview/Recent Development/Acquisitions
8.6 Biogen
  8.6.1 Biogen Profile
  8.6.2 Biogen Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Biogen Product/Solution Launches and Enhancements Analysis
  8.6.4 Biogen Business Overview/Recent Development/Acquisitions
8.7 Amgen
  8.7.1 Amgen Profile
  8.7.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Amgen Product/Solution Launches and Enhancements Analysis
  8.7.4 Amgen Business Overview/Recent Development/Acquisitions
8.8 Pfizer
  8.8.1 Pfizer Profile
  8.8.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.8.4 Pfizer Business Overview/Recent Development/Acquisitions

9 GLOBAL ADALIMUMAB MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Adalimumab Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Adalimumab Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Adalimumab Production Analysis from 2015-2020
10.4 North America Adalimumab Consumption Analysis from 2015-2020
10.5 North America Adalimumab Import and Export from 2015-2020
10.6 North America Adalimumab Value, Production and Market Share by Type (2015-2020)
10.7 North America Adalimumab Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Adalimumab by Country (United States, Canada)
  10.8.1 North America Adalimumab Sales by Country (2015-2020)
  10.8.2 North America Adalimumab Consumption Value by Country (2015-2020)
10.9 North America Adalimumab Market PEST Analysis

11 EUROPE

11.1 Europe Adalimumab Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Adalimumab Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Adalimumab Production Analysis from 2015-2020
11.4 Europe Adalimumab Consumption Analysis from 2015-2020
11.5 Europe Adalimumab Import and Export from 2015-2020
11.6 Europe Adalimumab Value, Production and Market Share by Type (2015-2020)
11.7 Europe Adalimumab Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Adalimumab by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Adalimumab Sales by Country (2015-2020)
  11.8.2 Europe Adalimumab Consumption Value by Country (2015-2020)
11.9 Europe Adalimumab Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Adalimumab Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Adalimumab Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Adalimumab Production Analysis from 2015-2020
12.4 Asia-Pacific Adalimumab Consumption Analysis from 2015-2020
12.5 Asia-Pacific Adalimumab Import and Export from 2015-2020
12.6 Asia-Pacific Adalimumab Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Adalimumab Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Adalimumab by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Adalimumab Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Adalimumab Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Adalimumab Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Adalimumab Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Adalimumab Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Adalimumab Production Analysis from 2015-2020
13.4 Latin America Adalimumab Consumption Analysis from 2015-2020
13.5 Latin America Adalimumab Import and Export from 2015-2020
13.6 Latin America Adalimumab Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Adalimumab Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Adalimumab by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Adalimumab Sales by Country (2015-2020)
  13.8.2 Latin America Adalimumab Consumption Value by Country (2015-2020)
13.9 Latin America Adalimumab Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Adalimumab Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Adalimumab Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Adalimumab Production Analysis from 2015-2020
14.4 Middle East & Africa Adalimumab Consumption Analysis from 2015-2020
14.5 Middle East & Africa Adalimumab Import and Export from 2015-2020
14.6 Middle East & Africa Adalimumab Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Adalimumab Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Adalimumab by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Adalimumab Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Adalimumab Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Adalimumab Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ADALIMUMAB MARKET FROM 2020-2027

15.1 Future Forecast of the Global Adalimumab Market from 2020-2027 Segment by Region
15.2 Global Adalimumab Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Adalimumab Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Adalimumab Market Value ($) and Growth Rate of Adalimumab from 2015-2027
Global Adalimumab Production and Growth Rate Segment by Product Type from 2015-2027
Global Adalimumab Consumption and Growth Rate Segment by Application from 2015-2027
Figure Adalimumab Picture
Table Product Specifications of Adalimumab
Table Driving Factors for this Market
Table Industry News of Adalimumab Market
Figure Value Chain Status of Adalimumab
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Adalimumab Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Adalimumab Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Rheumatoid Arthritis of Adalimumab
Figure Psoriatic Arthritis of Adalimumab
Figure Psoriasis of Adalimumab
Figure Crohn’s disease of Adalimumab
Figure Ulcerative colitis of Adalimumab
Table Global Adalimumab Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Adalimumab Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Adults of Adalimumab
Figure Children of Adalimumab
Table Global Adalimumab Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Adalimumab Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Adalimumab
Figure Online Channel of Adalimumab
Table AbbVie Profile (Company Name, Plants Distribution, Sales Region)
Figure AbbVie Sales and Growth Rate from 2015-2020
Figure AbbVie Revenue ($) and Global Market Share from 2015-2020
Table AbbVie Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Mylan Profile (Company Name, Plants Distribution, Sales Region)
Figure Mylan Sales and Growth Rate from 2015-2020
Figure Mylan Revenue ($) and Global Market Share from 2015-2020
Table Mylan Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sandoz Profile (Company Name, Plants Distribution, Sales Region)
Figure Sandoz Sales and Growth Rate from 2015-2020
Figure Sandoz Revenue ($) and Global Market Share from 2015-2020
Table Sandoz Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biogen Profile (Company Name, Plants Distribution, Sales Region)
Figure Biogen Sales and Growth Rate from 2015-2020
Figure Biogen Revenue ($) and Global Market Share from 2015-2020
Table Biogen Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Amgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Amgen Sales and Growth Rate from 2015-2020
Figure Amgen Revenue ($) and Global Market Share from 2015-2020
Table Amgen Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Adalimumab Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Adalimumab Production Value ($) by Region from 2015-2020
Table Global Adalimumab Production Value Share by Region from 2015-2020
Table Global Adalimumab Production by Region from 2015-2020
Table Global Adalimumab Consumption Value ($) by Region from 2015-2020
Table Global Adalimumab Consumption by Region from 2015-2020
Table North America Adalimumab Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Adalimumab Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Adalimumab Import and Export from 2015-2020
Table North America Adalimumab Value ($) by Type (2015-2020)
Table North America Adalimumab Production by Type (2015-2020)
Table North America Adalimumab Consumption by Application (2015-2020)
Table North America Adalimumab Consumption by Country (2015-2020)
Table North America Adalimumab Consumption Value ($) by Country (2015-2020)
Figure North America Adalimumab Market PEST Analysis
Table Europe Adalimumab Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Adalimumab Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Adalimumab Import and Export from 2015-2020
Table Europe Adalimumab Value ($) by Type (2015-2020)
Table Europe Adalimumab Production by Type (2015-2020)
Table Europe Adalimumab Consumption by Application (2015-2020)
Table Europe Adalimumab Consumption by Country (2015-2020)
Table Europe Adalimumab Consumption Value ($) by Country (2015-2020)
Figure Europe Adalimumab Market PEST Analysis
Table Asia-Pacific Adalimumab Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Adalimumab Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Adalimumab Import and Export from 2015-2020
Table Asia-Pacific Adalimumab Value ($) by Type (2015-2020)
Table Asia-Pacific Adalimumab Production by Type (2015-2020)
Table Asia-Pacific Adalimumab Consumption by Application (2015-2020)
Table Asia-Pacific Adalimumab Consumption by Country (2015-2020)
Table Asia-Pacific Adalimumab Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Adalimumab Market PEST Analysis
Table Latin America Adalimumab Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Adalimumab Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Adalimumab Import and Export from 2015-2020
Table Latin America Adalimumab Value ($) by Type (2015-2020)
Table Latin America Adalimumab Production by Type (2015-2020)
Table Latin America Adalimumab Consumption by Application (2015-2020)
Table Latin America Adalimumab Consumption by Country (2015-2020)
Table Latin America Adalimumab Consumption Value ($) by Country (2015-2020)
Figure Latin America Adalimumab Market PEST Analysis
Table Middle East & Africa Adalimumab Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Adalimumab Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Adalimumab Import and Export from 2015-2020
Table Middle East & Africa Adalimumab Value ($) by Type (2015-2020)
Table Middle East & Africa Adalimumab Production by Type (2015-2020)
Table Middle East & Africa Adalimumab Consumption by Application (2015-2020)
Table Middle East & Africa Adalimumab Consumption by Country (2015-2020)
Table Middle East & Africa Adalimumab Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Adalimumab Market PEST Analysis
Table Global Adalimumab Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Adalimumab Production and Growth Rate Forecast by Region (2020-2027)
Table Global Adalimumab Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Adalimumab Production and Growth Rate Forecast by Type (2020-2027)
Table Global Adalimumab Consumption and Growth Rate Forecast by Application (2020-2027)